Our results indicated that these genes' (TP53, TTN, MUC16, RYR2, CSMD3, USH2A, LRP1B, ZFHX4, SYNE1, and XIRP2) mutations are frequently present in clinical lung cancer patients (Figure 4(a)). The gene discussed is TP53; the disease is lung cancer.